BELLEVUE, Wash., May 18, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a Nevada corporation, announced today that the Company entered into a definitive purchase agreement on May 17, 2010 with accredited investors to place Senior Secured Convertible Notes (collectively, “Notes”) totaling $1.53 million. The net proceeds of the financing will be used for the development of certain partnerships and for general working capital. The Company expects the transaction to close within two days of the execution of such purchase agreement, subject to the satisfaction of customary closing conditions.
